Antithrombin- aktivitetsniveauet skal opretholdes over 80% under hele behandlingen, med mindre kliniske forhold indikerer et andet effektivitetsniveau.
The antithrombin activity level should be maintained above 80% for the duration of the treatment, unless clinical particulars would indicate a different effective level.